Atrial Fibrillation Market Size, Share, Growth Analysis, By Technology(Radiofrequency, Laser, Cryotherapy, and Others), By End User(Hospitals, Specialty Clinics, Others), By Region - Industry Forecast 2024-2031

Global Atrial Fibrillation Market size was valued at USD 10.10 billion in 2022 and is poised to grow from USD 11.31 billion in 2023 to USD 27.92 billion by 2031, at a CAGR of 11.96% during the forecast period (2024-2031).

Atrial fibrillation (AFib) is known as irregular and frequently rapid heart rhythm. It is also known as an arrhythmia. Atrial fibrillation results in the formation of blood clots in the heart.

The growth of the atrial fibrillation market is driven by an increased incidence of atrial fibrillation among the geriatric population, technological advancements, and an increasing preference for catheter ablation in the treatment of Atrial fibrillation.

For instance, according to the Centers for Disease Control and Prevention (CDC), around 2% of individuals under the age of 65 are affected by AFib, whereas approximately 9% of those aged 65 and above are diagnosed with the condition.

However, the challenges in the market are a shortage of experienced specialists and high-cost treatment of atrial fibrillation. Additionally, the surge in the use of laser and radiofrequency applications, and potentially diminishing the necessity for atrial fibrillation devices are propelling the market growth.

Furthermore, the synergistic use of medications and devices is demonstrated to yield improved outcomes in the management of cardiac arrhythmias, contributing to potential expansion in the atrial fibrillation market throughout the forecast period.

Moreover, the increasing prevalence of atrial fibrillation is poised to fuel market expansion in the upcoming years.

For instance, according to the Journal of the American Heart Association in the U.S., a minimum of 3 to 6 million individuals currently live with AF, and projected to rise approximately 6 to 16 million by 2050. In Europe, the prevalence of AF in 2010 was around 9 million among individuals aged over 55, and it is anticipated to increase to 14 million by 2060. Estimates suggest that by 2050, AF diagnoses may encompass at least 72 million individuals in Asia.